Clinical Trial Update: Liposomal Bupivacaine With Standard Bupivacaine Versus Dexmedetomidine With Standard Bupivacaine [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing liposomal bupivacaine with standard bupivacaine versus dexmedetomidine with standard bupivacaine for acute pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Bupivacaine (Bupivacaine)
• Dexmedetomidine (Precedex) (dexmedetomidine)
• Liposomal Bupivacaine (Exparel) (bupivacaine liposome injectable suspension)

Snippet

Sponsor: The University of Hong Kong | Conditions: Acute Pain | Phase 3 | Status: COMPLETED